1. Lysyl oxidase‐like 2 inhibitor rescues D‐galactose‐induced skeletal muscle fibrosis
   Yongxin Wu et al, 2022, Aging Cell CrossRef
2. Targeting lysyl oxidase like 2 attenuates OVA-induced airway remodeling partly via the AKT signaling pathway
   Rong Zeng et al, 2024, Respiratory Research CrossRef
3. Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3
   Alison D. Findlay et al, 2019, Journal of Medicinal Chemistry CrossRef
4. Serum Copper-to-Zinc Ratio and Risk of Chronic Obstructive Pulmonary Disease: A Cohort Study
   Setor K. Kunutsor et al, 2023, Lung CrossRef
5. Protective effect of melatonin entrapped PLGA nanoparticles on radiation-induced lung injury through the miR-21/TGF-β1/Smad3 pathway
   Shuang Wang et al, 2021, International Journal of Pharmaceutics CrossRef
6. Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
   Tianyi Liu et al, 2019, Frontiers in Cell and Developmental Biology CrossRef
7. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway
   Yingbiao Wu et al, 2022, Cerebrovascular Diseases CrossRef
8. SPECT Imaging of Lysyl Oxidase-like 2 in a Model of Idiopathic Pulmonary Fibrosis
   Romane Vizier et al, 2023, Molecular Pharmaceutics CrossRef
9. Copper homeostasis dysregulation in respiratory diseases: a review of current knowledge
   Wei Song et al, 2024, Frontiers in Physiology CrossRef